Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma

BACKGROUND: Diagnosis of pancreatic ductal adenocarcinoma (PDAC) is difficult due to the lack of specific symptoms and screening methods. Only less than 10% of PDAC patients are candidates for surgery at the time of diagnosis. Thus, there is a great global unmet need for valuable biomarkers that cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ying-Ying, Guo, Kai, Zhao, Rui, Li, Yuan, Lv, Xiao-Jing, Lu, Zi-Peng, Tian, Lei, Ren, Shuai, Wang, Zhong-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259126/
https://www.ncbi.nlm.nih.gov/pubmed/37312938
http://dx.doi.org/10.1177/20552076231179007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259126/
https://www.ncbi.nlm.nih.gov/pubmed/37312938
http://dx.doi.org/10.1177/20552076231179007

Ejemplares similares